Depression and Inflammation Predict Depression Trajectory of Non-Small Cell Lung Cancer Patients

Area of Science:

• Oncology
• Psychiatry
• Immunology

Background:

• Depression and systemic inflammation are linked to poor outcomes in lung cancer patients.
• The interaction between these factors and psychological morbidity is not well understood.
• This study investigates the combined impact of depression and inflammation on depressive symptom trajectories.

Purpose of the Study:

• To determine if the co-occurrence of depression and systemic inflammation predicts a worsened trajectory of depressive symptoms in lung cancer patients.
• To explore the interaction of depression and inflammation as biomarkers for psychological morbidity.
• To identify potential biobehavioral metrics for depression maintenance in lung cancer.

Main Methods:

• An observational longitudinal cohort study (N=182) of advanced non-small cell lung cancer patients.
• Assessed depressive symptoms (Patient Health Questionnaire-9) and systemic inflammation (Advanced Lung Cancer Inflammation Index) at diagnosis and monthly for 8 months.
• Subdivided patients into four cohorts based on validated cutoffs for depression and inflammation.

Main Results:

• Depressive symptoms did not significantly change over time for the overall cohort (P=0.26).
• A significant interaction effect was observed for the "Depression+Inflammation" cohort, indicating an elevated depression trajectory (P=0.001).
• This suggests that patients with both high depression and high inflammation experienced worsening depressive symptoms.

Conclusions:

• Co-occurring depression and systemic inflammation predict a worsening trajectory of depressive symptoms in lung cancer patients.
• This finding contributes to understanding depression pathophysiology in cancer.
• The study proposes a novel biobehavioral metric for identifying persistent depression in this population.